Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'APOMORPHINE TEST' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 30 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Albanese, A; Bonuccelli, U; Brefel, C; Chaudhuri, KR; Colosimo, C; Eichhorn, T; Melamed, E; Pollak, P; Van Laar, T; Zappia, M
      Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease

      MOVEMENT DISORDERS
    2. Homann, CN; Suppan, K; Wenzel, K; Giovannoni, G; Ivanic, G; Horner, S; Ott, E; Hartung, HP
      The bradykinesia akinesia incoordination test (BRAIN TEST (c)), an objective and user-friendly means to evaluate patients with parkinsonism

      MOVEMENT DISORDERS
    3. Benamer, HTS; Patterson, J; Wyper, DJ; Hadley, DM; Macphee, GJA; Grosset, DG
      Correlation of Parkinson's disease severity and duration with I-123-FP-CITSPECT striatal uptake

      MOVEMENT DISORDERS
    4. Benamer, HTS; Patterson, J; Grosset, DG; Booij, J; de Bruin, K; van Royen, E; Speelman, JD; Horstink, MHIM; Sips, HJWA; Dierckx, RA; Versijpt, J; Decoo, D; Van der Linden, C; Hadley, DM; Doder, M; Lees, AJ; Costa, DC; Gacinovic, S; Oertel, WH; Pogarell, O; Hoeffken, H; Joseph, K; Tatsch, K; Schwarz, J; Ries, V
      Accurate differentiation of parkinsonism and essential tremor using visualassessment of [I-123]-FP-CIT SPECT imaging: The [I-123]-FP-CIT study group

      MOVEMENT DISORDERS
    5. Ogawa, N
      Factors affecting levodopa effects in Parkinson's disease

      ACTA MEDICA OKAYAMA
    6. Brambilla, F; Perna, G; Bussi, R; Bellodi, L
      Dopamine function in obsessive compulsive disorder: cortisol response to acute apomorphine stimulation

      PSYCHONEUROENDOCRINOLOGY
    7. Duval, F; Mokrani, MC; Crocq, MA; Bailey, PE; Diep, TS; Correa, H; Macher, JP
      Dopaminergic function and the cortisol response to dexamethasone in psychotic depression

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    8. Schrag, A; Schelosky, L; Scholz, U; Poewe, W
      Reduction of parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challenges

      MOVEMENT DISORDERS
    9. Andreu, N; Chale, JJ; Senard, JM; Thalamas, C; Montastruc, JL; Rascol, O
      L-Dopa-induced sedation: a double-blind cross-over controlled study versustriazolam and placebo in healthy volunteers

      CLINICAL NEUROPHARMACOLOGY
    10. Pinter, MM; Alesch, F; Murg, M; Helscher, RJ; Binder, H
      Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus

      JOURNAL OF NEUROLOGY
    11. Moller, JC; Pogarell, O; Oertel, WH
      Diagnosis of Parkinson's disease

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    12. COOLS AR; GINGRAS MA
      NIJMEGEN HIGH AND LOW RESPONDERS TO NOVELTY - A NEW TOOL IN THE SEARCH AFTER THE NEUROBIOLOGY OF DRUG-ABUSE LIABILITY

      Pharmacology, biochemistry and behavior
    13. SCHWARZ J; TATSCH K; GASSER T; ARNOLD G; OERTEL WH
      [(123)]IBZM BINDING PREDICTS DOPAMINERGIC RESPONSIVENESS IN PATIENTS WITH PARKINSONISM AND PREVIOUS DOPAMINOMIMETIC THERAPY

      Movement disorders
    14. ZAPPIA M; MONTESANTI R; COLAO R; BRANCA D; NICOLETTI G; AGUGLIA U; QUATTRONE A
      SHORT-TERM LEVODOPA TEST ASSESSED BY MOVEMENT TIME ACCURATELY PREDICTS DOPAMINERGIC RESPONSIVENESS IN PARKINSONS-DISEASE

      Movement disorders
    15. VANHILTEN JJ; WAGEMANS EAH; GHAFOERKHAN SF; VANLAAR T
      MOVEMENT CHARACTERISTICS IN PARKINSONS-DISEASE - DETERMINATION OF DOPAMINERGIC RESPONSIVENESS AND THRESHOLD

      Clinical neuropharmacology
    16. MOKRANI MC; DUVAL F; CROCQ MA; BAILEY P; MACHER JP
      HPA AXIS DYSFUNCTION IN DEPRESSION - CORRELATION WITH MONOAMINE SYSTEM ABNORMALITIES

      Psychoneuroendocrinology
    17. TISSINGH G; BOOIJ J; WINOGRODZKA A; VANROYEN EA; WOLTERS EC
      IBZM-SPECT AND CIT-SPECT OF THE DOPAMINERGIC SYSTEM IN PARKINSONISM

      Journal of neural transmission. Supplementum
    18. BRAMBILLA F; BELLODI L; PERNA G; ARANCIO C; BERTANI A
      DOPAMINE FUNCTION IN OBSESSIVE-COMPULSIVE DISORDER - GROWTH-HORMONE RESPONSE TO APOMORPHINE STIMULATION

      Biological psychiatry
    19. EICHHORN TE; GASSER T; MAI N; MARQUARDT C; ARNOLD G; SCHWARZ J; OERTEL WH
      COMPUTATIONAL ANALYSIS OF OPEN-LOOP HANDWRITING MOVEMENTS IN PARKINSONS-DISEASE - A RAPID METHOD TO DETECT DOPAMIMETIC EFFECTS

      Movement disorders
    20. SCHWARZ J; OERTEL WH; TATSCH K
      IODINE-123-IODOBENZAMIDE BINDING IN PARKINSONISM - REDUCTION BY DOPAMINE AGONISTS BUT NOT L-DOPA

      The Journal of nuclear medicine
    21. LUIJCKX GJ; NIEUWHOF C; TROOST J; WEBER WEJ
      PARKINSONISM IN ALCOHOL-WITHDRAWAL - CASE-REPORT AND REVIEW OF THE LITERATURE

      Clinical neurology and neurosurgery
    22. OERTEL WH; TRENKWALDER C; GASSER T; SCHWARZ J; BUCHER SF; EICHHORN T; POGARELL O; KUNIG G; ARNOLD G; BANDMANN O; DODEL RC
      EPIDEMIOLOGIC, GENETIC, PHARMACOLOGICAL, KINESIOLOGICAL, NUCLEAR MEDICAL (IBZM-SPECT), STANDARD AND FUNCTIONAL MRI STUDIES ON PARKINSONS-DISEASE AND RELATED DISORDERS AND ECONOMIC-EVALUATION OF PARKINSONS-DISEASE THERAPY - CLINICAL PROJECTS IN THE BMFT-RESEARCH PROGRAM MUNICH - PARKINSONS-DISEASE AND OTHER BASAL GANGLIA DISORDERS

      Journal of neural transmission. Supplementum
    23. PITCHOT W; HANSENNE M; MORENO AG; ANSSEAU M
      EFFECT OF PREVIOUS ANTIDEPRESSANT THERAPY ON THE GROWTH-HORMONE RESPONSE TO APOMORPHINE

      Neuropsychobiology
    24. HANSENNE M; PITCHOT W; MORENO AG; PAPART P; TIMSITBERTHIER M; ANSSEAU M
      CATECHOLAMINERGIC FUNCTION AND P300 AMPLITUDE IN MAJOR DEPRESSIVE DISORDER (P300 AND CATECHOLAMINES)

      Electroencephalography and clinical neurophysiology. Evoked potentials
    25. REICHE W; GRUNDMANN M; HUBER G
      DOPAMINE D-2-RECEPTOR SPECT WITH [I-123] IODOBENZAMIDE IN THE DIAGNOSIS OF PARKINSONS SYNDROME

      Radiologe
    26. BAKHEIT AMO
      EARLY DIAGNOSIS OF PARKINSONS-DISEASE

      Postgraduate medical journal
    27. DCOSTA DF; SHEEHAN LJ; PHILLIPS PA; MOORESMITH B
      THE LEVODOPA TEST IN PARKINSONS-DISEASE

      Age and ageing
    28. HIERHOLZER J; CORDES M; SCHELOSKY L; SANDER B; BOCK JC; DAVID I; HOROWSKI R; POEWE W
      DIFFERENTIAL-DIAGNOSIS IN PATIENTS WITH E XTRAPYRAMIDAL MOVEMENT-DISORDERS - I-123 IBZM-SPECT VS APOMORPHINE-TEST

      RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren
    29. SCHELOSKY L; HIERHOLZER J; WISSEL J; CORDES M; POEWE W
      CORRELATION OF CLINICAL-RESPONSE IN APOMORPHINE TEST WITH D(2)-RECEPTOR STATUS AS DEMONSTRATED BY I-123 IBZM-SPECT

      Movement disorders
    30. PINTER MM; HELSCHER RJ; SATTLER AP
      APOMORPHINE TEST IN IDIOPATHIC PARKINSONI AN SYNDROME-DOSAGE AND CORRESPONDING PARAMETERS

      Wiener Klinische Wochenschrift


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 22:37:27